Clinical Trial Update: Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function [Phase 1]

View source ↗

Summary

This completed Phase 1 study assesses how kidney function affects the pharmacokinetics of conivaptan, comparing mild/moderate impairment to normal kidney functi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Kidney Diseases

Drugs mentioned

• Vaprisol (Conivaptan)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Kidney Diseases, Hyponatremia | Phase 1 | Status: COMPLETED